Post by
Zibo510 on Feb 10, 2024 7:57am
Last NR
Biodex sales projections have been increased by 7.5%, but desdespite many recent NR's regarding Biodex EVMT has never released any estimates as to projected sales volume of Biodex products.
Biodex was acquired in April 2023 and was expected to add 26 million in yearly revenue.
Former director Kyle Wilkes left the company and formed VMS to become an exclusive distributor of Biodex products.
EVMT is just about to launch sales of new Biodex products.
Although we don't have sales volume projections I have a feeling that we might be about to see a large increase in revenue from Biodex products.
Q1 2024 financials will give us an indication of what Biodex sales will add to yearly revenue.
I think 2024 will be a turning point for the value of the this stock. Big time.
Comment by
Zibo510 on Feb 11, 2024 2:02pm
Should read Seller's of Simbex LLC not Biodex
Comment by
TheProphetElijah on Feb 12, 2024 9:39am
Was the extra $26m already being taken into account previous quarters?
Comment by
Zibo510 on Feb 12, 2024 11:09am
I believe Biodex was generating 18mil a year prior to the acquisition and 26mil was a projection of anticipated revenue. I haven't been able to find a breakdown of income from the different divisions at least not in the MD&A Q4 year end financials should provide a better insight of revenue breakdown.
Comment by
TheProphetElijah on Feb 12, 2024 12:31pm
So potentially another $26m could be added to revenue, plus 7.5% ?